Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial
Published Online: 2013-11-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Angel H Bair•Bohuslav Melichar•Brian I Rini•Dmitri Pavlov•Eric Jonasch•Glen I Andrews•José A Arranz•Mayer N Fishman•Sinil Kim•Takeshi Ueda•Viktor Grünwald•Yazdi K Pithavala
